Open access
Sep 2026
Dynamic ctDNA Monitoring Predicts Recurrence and Guides Therapy in Postoperative Hepatocellular Carcinoma.
BACKGROUND Hepatocellular carcinoma (HCC) remains a global health challenge with high recurrence rates despite surgical resection. Current biomarkers lack sensitivity for early relapse detection, underscoring the need for novel strategies. Circulating tumor DNA (ctDNA) has emerged as a promising tool for minimal residu...
Jian-Liang Xu, Hui Wang, Ming-Xing Xu et al.
· Journal of Surgical Oncology · 0 citations